InMed Pharmaceuticals (INM) Earnings Analysis
InMed Pharmaceuticals (INM) next reports earnings on 2026-09-18, consensus EPS -94.44358 USD. Trailing P/E -0.00.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does INM next report earnings?
| Next earnings date | 2026-09-18 |
|---|---|
| Consensus EPS estimate | -94.44358 USD |
| Revenue estimate | n/a |
INM earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-11-06 | -0.44 USD | n/a | n/a | n/a |
| 2025-09-23 | -3.8 USD | n/a | n/a | n/a |
| 2025-05-12 | -1.94 USD | n/a | n/a | n/a |
| 2025-02-12 | -3.64 USD | n/a | n/a | n/a |
| 2024-11-14 | -54.2 USD | n/a | n/a | n/a |
INM valuation and analyst view
| Trailing P/E | -0.00 |
|---|---|
| Trailing EPS | -2.44851 USD |
| Price / book | 0.98 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is InMed Pharmaceuticals (INM)'s next earnings date?
InMed Pharmaceuticals is next scheduled to report on 2026-09-18, with a consensus EPS estimate of -94.44358 USD.
Did INM beat earnings last quarter?
Consensus estimate data was not available for INM's 2025-11-06 report.
What is INM's current P/E ratio and EPS?
INM trades at a trailing P/E of -0.00 on trailing EPS of -2.4485138983683896 USD.
What do analysts rate INM?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell).